{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:24:05Z","timestamp":1740137045765,"version":"3.37.3"},"reference-count":8,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T00:00:00Z","timestamp":1536105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust NZ J Obst Gynaeco"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:p>The Serious Transfusion Incident Reporting program (<jats:styled-content style=\"fixed-case\">STIR<\/jats:styled-content>) commenced haemovigilance in relation to RhD immunoglobulin (Ig) administration in 2015. During two years of reporting, 21 reports relating to RhD Ig administration were received. Thirty\u2010three percent (7\/21) were related to omission of RhD Ig, putting women at risk of RhD alloimmunisation and adverse consequences in future pregnancies. A recent case reported to <jats:styled-content style=\"fixed-case\">STIR<\/jats:styled-content> highlights poor communication and misinterpretation of pathology results leading to significant morbidity from haemolysis in the fetus. <jats:styled-content style=\"fixed-case\">STIR<\/jats:styled-content> makes recommendations related to education of staff and communication between clinical and laboratory staff to improve the safety of patient care.<\/jats:p>","DOI":"10.1111\/ajo.12889","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T06:18:30Z","timestamp":1536214710000},"page":"161-164","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Misinterpretation of blood group and antibody screen leading to serious errors in RhD immunoglobulin administration: A report on first two years of data from Serious Transfusion Incident Reporting program"],"prefix":"10.1111","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4880-7036","authenticated-orcid":false,"given":"Christine","family":"Akers","sequence":"first","affiliation":[{"name":"Blood Matters Department of Health and Human Services Serious Transfusion Incident Reporting Program  Melbourne Victoria Australia"},{"name":"Blood Matters Program  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Savoia","sequence":"additional","affiliation":[{"name":"Royal Women's Hospital  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5172-3263","authenticated-orcid":false,"given":"Stefan","family":"Kane","sequence":"additional","affiliation":[{"name":"Royal Women's Hospital  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4124-4971","authenticated-orcid":false,"given":"Philip","family":"Crispin","sequence":"additional","affiliation":[{"name":"Blood Matters Department of Health and Human Services Serious Transfusion Incident Reporting Program  Melbourne Victoria Australia"},{"name":"The Canberra Hospital  Canberra Australian Capital Territory Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastazia","family":"Keegan","sequence":"additional","affiliation":[{"name":"Blood Matters Department of Health and Human Services Serious Transfusion Incident Reporting Program  Melbourne Victoria Australia"},{"name":"Australian Red Cross Blood Service  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Wood","sequence":"additional","affiliation":[{"name":"Blood Matters Department of Health and Human Services Serious Transfusion Incident Reporting Program  Melbourne Victoria Australia"},{"name":"School of Public Health and Preventative Medicine Monash University  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget","family":"Glazebrook","sequence":"additional","affiliation":[{"name":"Blood Matters Department of Health and Human Services Serious Transfusion Incident Reporting Program  Melbourne Victoria Australia"},{"name":"Blood Matters Program  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linley","family":"Bielby","sequence":"additional","affiliation":[{"name":"Blood Matters Department of Health and Human Services Serious Transfusion Incident Reporting Program  Melbourne Victoria Australia"},{"name":"Blood Matters Program  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda K.","family":"Davis","sequence":"additional","affiliation":[{"name":"Blood Matters Department of Health and Human Services Serious Transfusion Incident Reporting Program  Melbourne Victoria Australia"},{"name":"Alfred Hospital  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,9,5]]},"reference":[{"key":"e_1_2_5_2_1","unstructured":"Australian Red Cross Blood Service.Anti\u2010D prophylaxis.https:\/\/transfusion.com.au\/disease_therapeutics\/fetomaternal\/HDN2017."},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31826d7dc1"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2009.181172"},{"key":"e_1_2_5_5_1","unstructured":"Bolton\u2010MaggsPHB(Ed)D Poles et al. on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2016 Annual SHOT Report (2017)"},{"key":"e_1_2_5_6_1","first-page":"25","article-title":"Obstetric management in Rh alloimmunizated pregnancy","volume":"3","author":"Cacciatore A","year":"2009","journal-title":"J Prenat Med"},{"key":"e_1_2_5_7_1","unstructured":"Australian and New Zealand Society of Blood Transfusion Guidelines for transfusion and Immunohaematology Laboratory Practice. 1st edition 2016."},{"volume-title":"Guidelines for the use of Rh(D) Immunoglobulin (Anti\u2010D) in obstetrics in Australia","year":"2015","author":"The Royal Australian and New Zealand College of Obstetricians and Gynaecologists","key":"e_1_2_5_8_1"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2010.01366.x"}],"container-title":["Australian and New Zealand Journal of Obstetrics and Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajo.12889","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajo.12889","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T21:04:17Z","timestamp":1694725457000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/ajo.12889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,5]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1111\/ajo.12889"],"URL":"https:\/\/doi.org\/10.1111\/ajo.12889","archive":["Portico"],"relation":{},"ISSN":["0004-8666","1479-828X"],"issn-type":[{"type":"print","value":"0004-8666"},{"type":"electronic","value":"1479-828X"}],"subject":[],"published":{"date-parts":[[2018,9,5]]},"assertion":[{"value":"2018-02-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}